Stage 4 to symptom-free: Kizi Kamasho’s shocking cancer reversal

The story of Kizi Kamasho, a 53-year-old from Luton, serves as a poignant reminder of the realities faced by those diagnosed with male breast cancer. In 2022, Kizi received the shocking news of his diagnosis, which had already spread to his lungs, bones, and lymph nodes. However, amidst the despair, a ray of hope emerged in the form of a groundbreaking drug—Trastuzumab.

Described by Kizi as “like an oasis in the desert,” Trastuzumab became a beacon of hope in his battle against stage four cancer. This “wonder drug”, specifically targeting the type of cancer he had, marked a turning point in his journey. Through pioneering research and advancements in medical science, Kizi found himself propelled toward a future filled with optimism

Pioneering Research and Promising Treatments

Kizi’s experience underscores the importance of ongoing research and innovation in oncology. The drug he was prescribed, trastuzumab, is just one example of the remarkable progress being made in cancer treatment. By targeting specific cancer subtypes, such as HER2-positive breast cancer, these medications are revolutionizing the way we approach cancer care.

HER2, present in every human cell, regulates growth and cell restoration.

According to the NHS website, Trastuzumab’s effectiveness may vary among individuals, requiring regular check-ups during treatment to ensure its efficacy.

Trastuzumab, prescribed medication, is administered in hospital or clinic settings either intravenously or via subcutaneous injection into the thigh.

Moreover, recent scans showing Kizi’s clearance of the disease highlight the effectiveness of these treatments in combating advanced-stage cancers. As Cancer Research UK reports, Kizi’s journey is a testament to the power of perseverance, medical breakthroughs, and the unwavering commitment of healthcare professionals.

Kizi Kamasho’s shocking cancer reversal

In healthcare, some topics remain largely unspoken, shrouded in misconceptions, and overlooked in medical discourse. Among these are male breast cancer and gynecomastia, conditions that affect a significant portion of the male population yet are often sidelined in discussions. As medical professionals, it’s crucial to shed light on these conditions, their prevalence, and the strides in their treatment.

Understanding Male Breast Cancer and Gynecomastia

Male breast cancer, though less common than its counterpart in women, is a reality that cannot be ignored. According to the American Cancer Society, approximately 2,650 new cases of invasive breast cancer will be diagnosed in men, with an estimated 530 deaths in 2024. While this accounts for only about 1% of all breast cancer cases, the impact on those affected cannot be understated. While this number pales in comparison to female diagnoses, it’s a reminder that breast cancer knows no gender boundaries.

Kizi Kamasho’s shocking cancer reversal

Gynecomastia, on the other hand, is a benign enlargement of male breast tissue. It’s a condition that can affect males of any age and is often a result of hormonal imbalances, medications, or underlying health issues. Though not life-threatening, like breast cancer, gynecomastia can have profound psychological effects on individuals, impacting self-esteem and quality of life.

A Call to Action

As doctors, we must continue to educate ourselves and our patients about the realities of male breast cancer and gynecomastia. By fostering open dialogue, challenging stigmas, and advocating for early detection and treatment, we can make meaningful strides toward improving outcomes and enhancing the quality of life for those affected by these conditions.

Kizi Kamasho’s journey reminds us that amidst the darkness of illness, a glimmer of hope exists—a hope fueled by research, innovation, and the unwavering human spirit. Let us stand together in the fight against male breast cancer and gynecomastia, ensuring that no one faces these challenges alone.


  1. Man treated for breast cancer given ‘wonder drug’ [Internet]. Accessed on June 05, 2024. Available at
  2. Enlarged Male Breast Tissue (Gynecomastia) [Clevelandclinic]. Accessed on June 05, 2024. Available at

About Docquity

If you need more confidence and insights to boost careers in healthcare, expanding the network to other healthcare professionals to practice peer-to-peer learning might be the answer. One way to do it is by joining a social platform for healthcare professionals, such as Docquity

Docquity is an AI-based state-of-the-art private & secure continual learning network of verified doctors, bringing you real-time knowledge from thousands of doctors worldwide. Today, Docquity has over 400,000 doctors spread across six countries in Asia. Meet experts and trusted peers across Asia where you can safely discuss clinical cases, get up-to-date insights from webinars and research journals, and earn CME/CPD credits through certified courses from Docquity Academy. All with the ease of a mobile app available on Android & iOS platforms!

Share it with

Similar Articles

Data Privacy Notice

This Privacy Notice shall be read in conjunction with the Privacy Policy to the extent this Notice does not mention or specify the particulars that should have been mentioned or specified relating to the Notice in pursuance of the provisions of the Data Protection Laws as applicable.

On having accessed or visited this Platform you the Noticee hereby voluntarily consent to and take notice of the fact that the personal data, by which or in relation whereto you the concerned Noticee is identifiable, shall be retained, stored, used, and may be processed by the Company for the purpose and in the manner, though legal, found suitable to it for commercial and/or some other reasons. The detailed specificity whereof may be found in the Privacy Policy. The consent provided herein may be withdrawn anytime by you, the Noticee, at its own volition by removing your profile or by writing to us at

As a Noticee, you shall have the right to grievance redressal, in relation to your consent or our use of your personal data, which you may address by writing to us at Should you, the Noticee, thereafter remain unsatisfied or dissatisfied with the resolution provided by us, you, the Noticee, may approach the concerned regulatory authority for the redressal of your grievance.

Thanks for exploring our medical content.

Create your free account or log in to continue reading.

Data Privacy Notice

By using this platform, you consent to our use of your personal data as detailed in our Privacy Policy, and acknowledge that we use cookies to improve your browsing experience